Zydus bags rights to market MonoFerric injection in India, Nepal from Pharmacosmos A/S of Denmark

Zydus Lifesciences Ltd on Friday said it has acquired rights to market MonoFerric (iron isomaltoside) injection, used to treat iron deficiency in adult patients, in India and Nepal from Denmark-based Pharmacosmos A/S. The financial details of the transaction have not been disclosed.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/qy6oPtG
via IFTTT